Switch View
© BusinessWire
22.10.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICON Reports Third Quarter 2025 Results
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today reported its financial results for the third quarter ended September 30, 2025.
CEO, Mr. Barry Balfe commented, “ICON’s results in quarter three were reflective of broad market conditions, as we continued to partner with customers to navigate an uncertain environment....
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: IE00B4Q5ZN47
Jazz Pharmaceuticals PLC
JAZZ
LISTED
NASDAQ
Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 5, 2025
News Preview
DUBLIN, Oct. 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 third quarter financial results on Wednesday, November 5, 2025, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. EST / 9:30 p.m. G...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US1124631045
Brookdale Senior Living Inc
BKD
LISTED
NYSE
Brookdale Announces Third Quarter 2025 Earnings Release and Conference Call Dates
News Preview
BRENTWOOD, Tenn., Oct. 22, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) will release its third quarter 2025 financial results after the close of the market on Thursday, November 6, 2025. In conjunction with this release, the Company will hold a conference call on Friday, November 7, 2025, at 8:00...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
22.10.2025
ISIN: IE00B4Q5ZN47
Jazz Pharmaceuticals PLC
JAZZ
LISTED
NASDAQ
Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 5, 2025
News Preview
DUBLIN, Oct. 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 third quarter financial results on Wednesday, November 5, 2025, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. EST / 9:30 p.m. G...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
22.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare Reports Third Quarter 2025 Financial Results
News Preview
Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third quarter 2025 GAAP earnings per diluted share of $1.51 and adjusted earnings per diluted share of $1.84. Financial results are summarized below:
Three months ended
Nine months ended
September 30,
September 30,
...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US58506Q1094
Medpace Holdings Inc
MEDP
LISTED
NASDAQ
Medpace Holdings, Inc. Reports Third Quarter 2025 Results
News Preview
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2025.
Third Quarter 2025 Financial Results
Revenue for the three months ended September 30, 2025 increased 23.7% to $659.9 million, compared to $533.3 million for the comparable prior-year period. On a constant currency...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US92686J1060
Viking Therapeutics Inc
VKTX
LISTED
NASDAQ
Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
Conference call scheduled for 4:30 p.m. ET today
Phase 3 VANQUISH Trials for Subcutaneous VK2735 in Obesity Proceeding on Schedule
VK2735 Phase 1 Maintenance Dosing Study Underway...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US09061G1013
BioMarin Pharmaceutical Inc
BMRN
LISTED
NASDAQ
BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET
News Preview
SAN RAFAEL, Calif., Oct. 22, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, October 27, 2025, at 4:30 p.m. ET to discuss third quarter 2025 financial result...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US0906831039
Biote Corp
BTMD
LISTED
NASDAQ
Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call
News Preview
biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide third quarter financial results on Wednesday, November 5, 2025, after the close of the market. A conference call t...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US1167941087
Bruker Corp
BRKR
LISTED
NASDAQ
Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2025 financial results before market opening on Monday, November 3, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
To listen to the webcast, investors can go to https://ir.bruker....
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US92764N1028
Vir Biotechnology Inc
VIR
LISTED
NASDAQ
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that the Company will provide a corporate update and report financial results for the third quarter ended September 30, 2025, on November 5, 2025. The Company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET on November 5, 2025.
The corporate update and financial results will be pr...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced it will report business updates and financial results for the third quarter 2025 after market close on Wednesday, November 5, 2025. Company management w...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
22.10.2025
ISIN: US14817C1071
Cassava Sciences Inc
SAVA
LISTED
NASDAQ
Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Cassava Sciences, Inc. (NASDAQ: SAVA) breached their fiduciary duties to shareholders.
If you currently own Cassava stock and acquired shares on or before September 14, 2020, you may be able to seek corporate governance reforms, the return o...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US7599101026
KORU Medical Systems Inc
KRMD
LISTED
NASDAQ
KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
News Preview
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2025 financial results on Wednesday...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US21900C3088
CorMedix Inc
CRMD
LISTED
NASDAQ
Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of CorMedix Inc. (NASDAQ: CRMD) breached their fiduciary duties to shareholders.
If you currently own CorMedix stock and acquired shares on or before October 16, 2019, you may be able to seek corporate governance reforms, the return of funds ba...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US2681582019
Dynavax Technologies Corp
DVAX
LISTED
NASDAQ
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
News Preview
EMERYVILLE, Calif., Oct. 22, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report third quarter 2025 financial results on Wednesday, November 5, 2025, after the U.S. financial markets clos...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US45720N1037
Inhibrx Biosciences Inc
INBX
LISTED
NASDAQ
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
News Preview
– Event to be webcast live on Thursday, October 23, 2025 at 1:30 p.m. PT –
SAN DIEGO, Oct. 22, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeuti...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
News Preview
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced the appointment of Suresh Gunasekaran to its Board of Directors.
Suresh currently serves as President and Chief Execu...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US56600D1072
Maravai LifeSciences Holdings Inc
MRVI
LISTED
NASDAQ
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
News Preview
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2025 financial and operating results after the market close on Thursday, November 6, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. P...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 clinical trial of TLX090 (153Samarium (Sm)-DOTMP), a therapeutic radiopharmaceutical candidate for treating pain asso...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US0042251084
ACADIA Pharmaceuticals Inc
ACAD
LISTED
NASDAQ
Halper Sadeh LLC Encourages Acadia Pharmaceuticals Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) breached their fiduciary duties to shareholders.
If you currently own Acadia stock and acquired shares on or before September 9, 2019, you may be able to seek corporate governance reforms, the retur...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: CA75150G1046
Ramm Pharma Corp.
RAMM
LISTED
CSE
RAMM Pharma Corp. Provides Update on Canada post strike and mailing of the Company´s meeting materials
News Preview
TORONTO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), wishes to notify shareholders that a disruption due to the ongoing Canada Post strike (the “Postal Strike”), and the recent update that mail will resume partial service, but there may still be delays, the Co...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 22, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 22, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US68236X1000
Oncology Institute Inc
TOI
LISTED
NASDAQ
The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call
News Preview
CERRITOS, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that the company will release its third quarter 2025 financial results after the market close on Thursday, November 13, 2025, to be followed by a conference call the same day at...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purc...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
News Preview
WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 UBS Global Healthcare Conference on Tuesday, November 11, 2025, at 11:00 a.m. Eastern Time....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US1266381052
CVRx Inc
CVRX
LISTED
NASDAQ
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
News Preview
MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release third quarter 2025 financial and operating re...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5, 2025, at 4:30 pm Eastern Time....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US68375N1037
OPKO Health Inc
OPK
LISTED
TLV
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
News Preview
MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial markets on Wednesday, October 29, 2025. OPKO’s senior management will provide a business update and discuss results as well as financi...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
FREMONT, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter 2025 after market close on Wednesday, November 5, 2025. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Paci...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: JP3110650003
Asahi Intecc Co Ltd
77470
LISTED
XJPX
Asahi Intecc USA Enters GI Market with Launch of Tornus ES and Fielder 18
News Preview
IRVINE, Calif., Oct. 22, 2025 /PRNewswire/ -- Asahi Intecc USA, a global leader in medical device technologies, proudly announces its official entry into the gastrointestinal (GI) market in the United States. Marking this strategic milestone, Asahi introduces two innovative endoscopic tools: Tornus ES (Endoscopic...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: VGG205281089
Charming Medical Ltd
MCTA
LISTED
NASDAQ
Charming Medical Limited Announces Closing of Initial Public Offering
News Preview
HONG KONG, Oct. 22, 2025 /PRNewswire/ -- Charming Medical Limited (Nasdaq: MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, today announced the closing of its initial public offering (the "Offering") of 1,600,000 Class A ordinary shares, par...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Larimar Therapeutics, Inc. (NASDAQ: LRMR) resulting from allegations that Larimar Therapeutics may have issued materially misleading business information to the investing public.
So What: If you purchased...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Deadline Approaching: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”).
IF YOU ARE AN INV...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
CarePlus Announces Medicare Advantage Plan Offerings for 2026
News Preview
CarePlus Health Plans, Inc., a provider of Medicare Advantage plans in Florida, today announced its 2026 Medicare Advantage plan offerings. With up to 12 plan options in each of the 20 Florida counties it serves, CarePlus remains focused on delivering robust coverage, preventive services, and exceptional member support.
“At CarePlus, we strive t...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: AU000000ANN9
Ansell Ltd
ANN
LISTED
ASX
Ansell Launches Expanded RightCycle™ Program to Help Industrial and Scientific Customers Divert PPE Waste from Landfills
News Preview
Ansell Limited (ASX: ANN), a global leader in safety solutions, today announced the launch of its expanded RightCycle™ Program. This enhanced sustainability initiative enables industrial and scientific customers to divert used PPE from landfills through recycling and a new energy recovery option using Alternative Engineered Fuels (AEFs)- a major s...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US04216R1023
Armata Pharmaceuticals, Inc.
ARMP
LISTED
XASE
Armata Pharmaceuticals Highlights Positive Results from Phase 2a diSArm Study of its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, in Late-Breaking Oral Presentation at IDWeek 2025™
News Preview
LOS ANGELES, Oct. 22, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that the MoonLake class action lawsuit – captioned Bridgewood v. MoonLake Immunotherapeutics, No. 25-cv-08500 (S.D.N.Y.) – seeks to represent purchasers or acquirers of MoonLake Immunotherapeutics (NASDAQ: MLTX) common stock and charges MoonLake as well as certain of MoonLake’s executi...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: INE044A01036
Sun Pharmaceutical Industries Ltd
SUNPHARMA
LISTED
BSE
Sun Pharma Announces Jeremy Allen as Vice President, Corporate Affairs for North America
News Preview
PRINCETON, N.J., Oct. 22, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) announced the appointment of Jeremy Allen as Vice President, Corporate Affairs for North A...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US2274831047
Cross Country Healthcare Inc
CCRN
LISTED
NASDAQ
Cross Country Marketing Team Wins Global OnCon Icon Award; Named No. 1 in the Nation
News Preview
Cross Country Healthcare (NASDAQ: CCRN) announced today that its marketing team has been named the No. 1 Marketing Team in the Nation by the 2025 OnCon Icon Awards, recognizing the best-in-class team’s creativity, innovation, measurable impact and leadership across both the healthcare and education industries and the broader marketing field.
This...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US44975P1030
I-Mab
IMAB
LISTED
NASDAQ
I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025
News Preview
ROCKVILLE, Md., Oct. 22, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (I-Mab or the Company), is a global biotechnology platform company committed to accelerating access to innovative medicines for patients worldwide, today announced that updated data from the Phase 1 study (NCT04900818) of givastomig as a monotherapy in heavily pre-treated pati...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US03237H1014
Amylyx Pharmaceuticals Inc
AMLX
LISTED
NASDAQ
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
News Preview
NEW YORK, Oct. 22, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US76155X1000
Revolution Medicines Inc
RVMD
LISTED
NASDAQ
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
News Preview
REDWOOD CITY, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated clinical data for elironrasib, a RAS(ON) G12C-selective inhibitor, in previously treated patients with KRAS G12C non...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.10.2025
ISIN: US60770K1079
Moderna Inc
MRNA
LISTED
NASDAQ
Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
News Preview
Company to discontinue development of mRNA-1647 in congenital CMVCompany will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patientsCompany does not anticipate any impact to its 2025 financial guidance or its expectation of achieving breakeven in 2028CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, I...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: AU000000ANN9
Ansell Ltd
ANN
LISTED
ASX
ANSELL UNVEILS 'AXIS', IMMERSIVE CUSTOMER EXPERIENCE CENTERS DRIVING THE FUTURE OF SAFETY INNOVATION
News Preview
ISELIN, N.J., Oct. 22, 2025 /PRNewswire/ -- Ansell Limited (ASX: ANN), a global leader in safety solutions, today announced the opening of its first Ansell Xperience & Innovation Studio (AXIS) in Alpharetta, Georgia. As safety needs evolve at an unprecedented pace — driven by emerging risks, new technologies,...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
UFC® and Smith+Nephew announce multi-year extension of partnership
News Preview
Smith+Nephew to continue as UFC’s Preferred Sports Medicine Technology Partner...
Themefolio
Profiler
Peergroup
© Newsfile
22.10.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Announces Overall and Event Free Survival Key Subgroup Data for OST-HER2 in Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
News Preview
New York, New York--(Newsfile Corp. - October 22, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced additional overall and event free survival data generated from the Company's 41-patient Phase 2b clinical trial...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025
News Preview
DUBLIN, Oct. 22, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2025 financial results on Wednesday, November 5th, 2025, and host a conference call beginning at 8:30 A.M. (EST)....
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US80810D1037
Schrodinger Inc
SDGR
LISTED
NASDAQ
Schrödinger to Announce Third Quarter 2025 Financial Results on November 5
News Preview
Schrödinger (Nasdaq: SDGR) will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US90337L1089
US Physical Therapy Inc
USPH
LISTED
NYSE
U.S. Physical Therapy, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call Dates
News Preview
U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three months and nine months ended September 30, 2025, on Wednesday, November 5, 2025, after the stock market closes, with the confer...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US65487U1088
Nkarta Inc
NKTX
LISTED
NASDAQ
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, today announced it will be presenting a poster this Sunday in Chicago at the American College of Rheumatology (ACR) Convergence...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
AVDL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avadel Pharmaceuticals plc Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avadel Pharmaceuticals plc (NASDAQ: AVDL) to Alkermes plc is fair to Avadel shareholders. Under the terms of the proposed transaction, Avadel shareholders will receive $18.50 per share, plus a non-transferable contingent value right entitling holders to a potential...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: JP3942400007
Astellas Pharma Inc
45030
LISTED
XJPX
Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study
News Preview
Extensive and growing evidence continues to reinforce fezolinetant as an effective treatment for moderate to severe VMS associated with menopause
Preliminary analysis from OPTION-VMS observational study demonstrated fezolinetant leads to statistically significan...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US30052C1071
Evolus Inc
EOLS
LISTED
NASDAQ
Evolus to Report Third Quarter Financial Results on November 5, 2025
News Preview
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the U.S. financial markets close.
Evolus management will host a conference call and live webcast to discus...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: VGG312491084
Establishment Labs Holdings Inc
ESTA
LISTED
NASDAQ
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2025, before the market opens on Wednesday, November 5, 2025, and will host a confe...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US6412881053
Neuropace Inc
NPCE
LISTED
NASDAQ
NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025
News Preview
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the third quarter of 2025 after market close on Tuesday, November 4, 2025. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacif...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced data and presentations at the International Consortium on Newborn Sequencing (ICoNS), underscoring the company’s leadership in driving genomic newborn screening (gNBS) from research into real-world clinical implementation.
As the labor...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and development, leveraging combined strengths to accelerate the development and delivery of next-generation targeted therapies.
This agreement leverages an int...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US86627T1088
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
Summit Therapeutics Raises $500 Million in Private Placement
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that the Company has accepted offers from multiple leading biotech institutional and individual investors to purchase an aggregate of approximately 26.68 million shares of the Company’s common stock at $18.74 per share, the closing price on Tuesday, October...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
